ABEOW
Abeona Therapeutics Inc
Halal Rating :
Last Price
$0.17
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing gene and cell therapies for severe diseases and conditions. The company primarily develops novel treatments for rare genetic diseases. Their main focus is on developing therapies for patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) and other rare genetic diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Abeona Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.